Volitionrx (VNRX) Interest Coverage Ratio Growth (1y) (2019 - 2025)
Volitionrx (VNRX) Interest Coverage Ratio Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.39 Bn | 174.10 Bn | 6.27 Bn | -45.18% |
| 2 | Stryker | 128.38 Bn | 125.50 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 107.68 Bn | 98.46 Bn | 6.41 Bn | 59.82% |
| 4 | Boston Scientific | 67.98 Bn | 66.53 Bn | 3.61 Bn | -80.85% |
| 5 | Edwards Lifesciences | 47.81 Bn | 44.13 Bn | 1.29 Bn | 11.06% |
| 6 | GE HealthCare Technologies | 28.53 Bn | 26.25 Bn | 1.98 Bn | -6.18% |
| 7 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 189.50% |
| 8 | Smith & Nephew | 26.78 Bn | 26.20 Bn | - | - |
| 9 | Koninklijke Philips | 25.34 Bn | 22.21 Bn | 2.07 Bn | -54.61% |
| 10 | Volitionrx | 93,277.10 | -1.02 Mn | - | 192.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 192.75% |
| Sep 30, 2025 | 87.84% |
| Jun 30, 2025 | 6.06% |
| Mar 31, 2025 | 24.97% |
| Dec 31, 2024 | 58.52% |
| Sep 30, 2024 | -312.34% |
| Jun 30, 2024 | 6.21% |
| Mar 31, 2024 | -26.98% |
| Dec 31, 2023 | -7.70% |
| Sep 30, 2023 | 10.42% |
| Jun 30, 2023 | 92.47% |
| Mar 31, 2023 | 2.90% |
| Dec 31, 2022 | 43.99% |
| Sep 30, 2022 | -36.30% |
| Jun 30, 2022 | -2,139.75% |
| Mar 31, 2022 | -44.91% |
| Dec 31, 2021 | -70.81% |
| Sep 30, 2021 | 73.72% |
| Jun 30, 2021 | 95.78% |
| Mar 31, 2021 | -105.71% |